I agree that this site is using cookies. You can find further informations here.
X
Charbonnel, B.
359  results:
Search for persons X
?
1

POS-354 WORSENING KIDNEY DISEASE INFLUENCES THE EFFICACY OF..:

Cherney, D. ; Charbonnel, B. ; Cosentino, F....
Kidney International Reports.  6 (2021)  4 - p. S154-S155 , 2021
Link: https://doi.org/10.1016/..
 
?
2

Cardiorenal outcomes with ertugliflozin by baseline metform..:

Cosentino, F ; Cannon, C P ; Cherney, D Z I...
European Heart Journal.  42 (2021)  Supplement_1 - p. , 2021
Link: https://doi.org/10.1093/..
 
?
3

Glycaemic control and hypoglycaemia risk with insulin glarg..:

Yale, J.-F. ; Aroda, V.R. ; Charbonnel, B....
Diabetes & Metabolism.  46 (2020)  2 - p. 110-118 , 2020
Link: https://doi.org/10.1016/..
 
?
4

Étude du maintien des traitements par insuline basale et fr..:

Roussel, R. ; Detournay, B. ; Teissier, C....
Annales d'Endocrinologie.  81 (2020)  4 - p. 265 , 2020
Link: https://doi.org/10.1016/..
 
?
5

Efficacy and adherence of glucagon-like peptide-1 receptor ..:

Guerci, B. ; Charbonnel, B. ; Gourdy, P....
Diabetes & Metabolism.  45 (2019)  6 - p. 528-535 , 2019
Link: https://doi.org/10.1016/..
 
?
6

Predicting severe hypoglycaemia with self-monitoring of blo..:

Moutairou, A. ; Roussel, R. ; Charbonnel, B....
Diabetes & Metabolism.  43 (2017)  4 - p. 392-394 , 2017
Link: https://doi.org/10.1016/..
 
?
7

Short-term effect of severe hypoglycaemia on glycaemic cont..:

Moutairou, A. ; Roussel, R. ; Charbonnel, B....
Diabetes & Metabolism.  43 (2017)  2 - p. 187-190 , 2017
Link: https://doi.org/10.1016/..
 
?
8

After the LEADER trial and SUSTAIN-6, how do we explain the..:

Vergès, B. ; Charbonnel, B.
Diabetes & Metabolism.  43 (2017)  - p. 2S3-2S12 , 2017
Link: https://doi.org/10.1016/..
 
?
9

CO-04: Coût du diabète de type 2 en France:

Charbonnel, B. ; Simon, D. ; Dallongeville, J....
Diabetes & Metabolism.  42 (2016)  - p. A2 , 2016
Link: https://doi.org/10.1016/..
 
?
10

CA-126: Patients diabétiques de type 2 (DT2) âgés : équilib..:

Monnier, L. ; Aroda, V. ; Charbonnel, B....
Diabetes & Metabolism.  42 (2016)  - p. A69 , 2016
Link: https://doi.org/10.1016/..
 
?
11

CA-117: L'hypoglycémie est-elle un risque modifiable chez l..:

Charbonnel, B. ; Zhang, Q. ; Gerrits, C....
Diabetes & Metabolism.  42 (2016)  - p. A67 , 2016
Link: https://doi.org/10.1016/..
 
?
12

Which oral antidiabetic drug to combine with metformin to m..:

Gautier, J.F. ; Monguillon, P. ; Verier-Mine, O....
Diabetes Research and Clinical Practice.  116 (2016)  - p. 26-28 , 2016
Link: https://doi.org/10.1016/..
 
?
13

Epidemiology of Insulin-Treated Diabetic Patients in French..:

Charbonnel, B ; Roussel, R ; Detournay, B..
Value in Health.  19 (2016)  7 - p. A683 , 2016
Link: https://doi.org/10.1016/..
 
?
14

CA-109: Conséquences d'une hypoglycémie sévère sur le contr..:

Moutairou, A. ; Roussel, R. ; Charbonnel, B.
Diabetes & Metabolism.  42 (2016)  - p. A64-A65 , 2016
Link: https://doi.org/10.1016/..
 
?
15

CA-069: Prise en charge thérapeutique des patients diabétiq..:

Simon, D. ; Dallongeville, J. ; Charbonnel, B....
Diabetes & Metabolism.  42 (2016)  - p. A53-A54 , 2016
Link: https://doi.org/10.1016/..
 
1-15